Dollar General names Deckard to expanded role
Dollar General Corp. executive vice president of store operations Steve Sunderland plans to leave the company effective January 19, the company said.
Latest
Health care outlook 2024: Sheila Arquette, president and CEO, NASP
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive.
Health care outlook 2024: Sandra Hanna, CEO, Neighbourhood Pharmacies
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada.
Health care outlook 2024: B. Douglas Hoey CEO, NCPA
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people.
Health care outlook 2024: Lee Ann Stember, president and CEO, NCPDP
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
Health care outlook 2024: Peter Matz, director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review.
Health care outlook 2024: Michael Hogue, CEO, APhA
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review.
Health care outlook 2024: Susan Cantrell, CEO, AMCP
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
HDA issues statement on FDA approval of Florida’s Rx drug importation plan
Healthcare Distribution Alliance (HDA) president and CEO Chip Davis released the following statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and
Ethel M Chocolates celebrates Valentine’s Day with new offerings
Ethel M Chocolates, proudly part of Mars, announced new Valentine’s Day offerings including gourmet limited-edition chocolates and seasonal favorites to delight chocolate lovers everywhere.
CVS Health announces leadership appointments
CVS Health announced several leadership updates, effective immediately: • Senior vice president of Corporate Finance and interim CFO, Tom Cowhey, has been formally appointed the company’s next CFO.
CVS Pharmacy unveils more simplified loyalty experience
CVS Pharmacy announced the evolution of its loyalty program to include two membership tiers: ExtraCare and ExtraCare Plus.
Nomo International to show essential care kit at CES
LAS VEGAS – Nomo International announces the first-of-its-kind smart technology for the millions of people providing personal care to family members, especially those facing health challenges will be on display at CES. Live on Walmart.
Sanpellegrino unveils zero grams added sugar Italian sparkling drinks
The La Dolce Vita lifestyle you’re craving is just one sip away. This new year, embrace what Italians affectionately call “the good life” with all-new Sanpellegrino Zero Grams Added Sugar Italian Sparkling Drinks.
WBA beats Q1 projections, cuts dividend
Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades.
CVS partially dropping Humira in favor of cheaper biosimilars
CVS Caremark, a CVS Health company, announced this week the continuation of its efforts to expand adoption of biosimilars. Effective April 1, 2024, Humira will be removed from our major national commercial template formularies and Humira biosimilars will be covered.